Zeng BY - Search Results

1

Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset.

Jenner P, Zeng BY, Smith LA, Pearce RK, Tel B, Chancharme L, Moachon G. Jenner P, et al. Among authors: zeng by. Exp Brain Res. 2000 Jul;133(2):178-88. doi: 10.1007/s002210000370. Exp Brain Res. 2000. PMID: 10968218

2

Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with levodopa.

Kuoppamäki M, Al-Barghouthy G, Jackson M, Smith L, Zeng BY, Quinn N, Jenner P. Kuoppamäki M, et al. Among authors: zeng by. Mov Disord. 2002 Nov;17(6):1312-7. doi: 10.1002/mds.10263. Mov Disord. 2002. PMID: 12465074

3

Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease.

Cannizzaro C, Tel BC, Rose S, Zeng BY, Jenner P. Cannizzaro C, et al. Among authors: zeng by. Brain Res Mol Brain Res. 2003 Feb 20;110(2):169-76. doi: 10.1016/s0169-328x(02)00555-7. Brain Res Mol Brain Res. 2003. PMID: 12591154

4

Unilateral pallidotomy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets exhibiting levodopa-induced dyskinesia.

Iravani MM, Costa S, Al-Bargouthy G, Jackson MJ, Zeng BY, Kuoppamäki M, Obeso JA, Jenner P. Iravani MM, et al. Among authors: zeng by. Eur J Neurosci. 2005 Sep;22(6):1305-18. doi: 10.1111/j.1460-9568.2005.04308.x. Eur J Neurosci. 2005. PMID: 16190886

5

Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets.

Zeng BY, Balfour RH, Jackson MJ, Rose S, Jenner P. Zeng BY, et al. J Neural Transm (Vienna). 2010 Jan;117(1):45-51. doi: 10.1007/s00702-009-0315-9. Epub 2009 Sep 22. J Neural Transm (Vienna). 2010. PMID: 19771390

6

A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Bukhatwa S, Zeng BY, Rose S, Jenner P. Bukhatwa S, et al. Among authors: zeng by. Brain Res. 2010 Apr 22;1326:174-83. doi: 10.1016/j.brainres.2010.02.045. Epub 2010 Feb 20. Brain Res. 2010. PMID: 20176003

7

The effects of dose and route of administration of PSI on behavioural and biochemical indices of neuronal degeneration in the rat brain.

Bukhatwa S, Zeng BY, Rose S, Jenner P. Bukhatwa S, et al. Among authors: zeng by. Brain Res. 2010 Oct 1;1354:236-42. doi: 10.1016/j.brainres.2010.07.060. Epub 2010 Aug 3. Brain Res. 2010. PMID: 20678493

8

Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats.

Zeng BY, Dass B, Owen A, Rose S, Cannizzaro C, Tel BC, Jenner P. Zeng BY, et al. Neurosci Lett. 1999 Dec 3;276(2):71-4. doi: 10.1016/s0304-3940(99)00762-4. Neurosci Lett. 1999. PMID: 10624794

9

Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA.

Zeng BY, Pearce RK, MacKenzie GM, Jenner P. Zeng BY, et al. Eur J Neurosci. 2000 Mar;12(3):1096-104. doi: 10.1046/j.1460-9568.2000.00988.x. Eur J Neurosci. 2000. PMID: 10762340

10

Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study.

Zeng BY, Pearce RK, MacKenzie GM, Jenner P. Zeng BY, et al. J Neural Transm (Vienna). 2001;108(8-9):925-41. doi: 10.1007/s007020170013. J Neural Transm (Vienna). 2001. PMID: 11716146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters